377 related articles for article (PubMed ID: 26412354)
1. Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme.
Yao J; Hsu CH; Li Z; Kim TS; Hwang LP; Lin YC; Lin YY
Curr Pharm Des; 2015; 21(36):5256-66. PubMed ID: 26412354
[TBL] [Abstract][Full Text] [Related]
2. A review of recent advances in magnetic nanoparticle-based theranostics of glioblastoma.
Dhar D; Ghosh S; Das S; Chatterjee J
Nanomedicine (Lond); 2022 Jan; 17(2):107-132. PubMed ID: 35000429
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.
Bouras A; Kaluzova M; Hadjipanayis CG
J Neurooncol; 2015 Aug; 124(1):13-22. PubMed ID: 25981803
[TBL] [Abstract][Full Text] [Related]
4. Effective heating of magnetic nanoparticle aggregates for in vivo nano-theranostic hyperthermia.
Wang C; Hsu CH; Li Z; Hwang LP; Lin YC; Chou PT; Lin YY
Int J Nanomedicine; 2017; 12():6273-6287. PubMed ID: 28894366
[TBL] [Abstract][Full Text] [Related]
5. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.
Ganipineni LP; Danhier F; Préat V
J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958
[TBL] [Abstract][Full Text] [Related]
6. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
Sun L; Joh DY; Al-Zaki A; Stangl M; Murty S; Davis JJ; Baumann BC; Alonso-Basanta M; Kaol GD; Tsourkas A; Dorsey JF
J Biomed Nanotechnol; 2016 Feb; 12(2):347-56. PubMed ID: 27305768
[TBL] [Abstract][Full Text] [Related]
7. Engineering graphene oxide with ultrasmall SPIONs and smart drug release for cancer theranostics.
Luo Y; Tang Y; Liu T; Chen Q; Zhou X; Wang N; Ma M; Cheng Y; Chen H
Chem Commun (Camb); 2019 Feb; 55(13):1963-1966. PubMed ID: 30681672
[TBL] [Abstract][Full Text] [Related]
8. Theranostic nanoparticles enhance the response of glioblastomas to radiation.
Wu W; Klockow JL; Mohanty S; Ku KS; Aghighi M; Melemenidis S; Chen Z; Li K; Morais GR; Zhao N; Schlegel J; Graves EE; Rao J; Loadman PM; Falconer RA; Mukherjee S; Chin FT; Daldrup-Link HE
Nanotheranostics; 2019; 3(4):299-310. PubMed ID: 31723547
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.
Liao W; Fan S; Zheng Y; Liao S; Xiong Y; Li Y; Liu J
Curr Med Chem; 2019; 26(31):5862-5874. PubMed ID: 29768997
[TBL] [Abstract][Full Text] [Related]
10. Use of nanoparticles for drug delivery in glioblastoma multiforme.
Jain KK
Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
[TBL] [Abstract][Full Text] [Related]
11. An Advanced
Chan MH; Chen W; Li CH; Fang CY; Chang YC; Wei DH; Liu RS; Hsiao M
ACS Appl Mater Interfaces; 2021 Jun; 13(23):26759-26769. PubMed ID: 34076419
[TBL] [Abstract][Full Text] [Related]
12. Viewing the Emphasis on State-of-the-Art Magnetic Nanoparticles: Synthesis, Physical Properties, and Applications in Cancer Theranostics.
Kaliamurthi S; Demir-Korkmaz A; Selvaraj G; Gokce-Polat E; Wei YK; Almessiere MA; Baykal A; Gu K; Wei DQ
Curr Pharm Des; 2019; 25(13):1505-1523. PubMed ID: 31119998
[TBL] [Abstract][Full Text] [Related]
13. The use of magnetic nanoparticles in cancer theranostics: Toward handheld diagnostic devices.
Hajba L; Guttman A
Biotechnol Adv; 2016; 34(4):354-361. PubMed ID: 26853617
[TBL] [Abstract][Full Text] [Related]
14. Nanocarrier-based drug combination therapy for glioblastoma.
Zhao M; van Straten D; Broekman MLD; Préat V; Schiffelers RM
Theranostics; 2020; 10(3):1355-1372. PubMed ID: 31938069
[TBL] [Abstract][Full Text] [Related]
15. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
16. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
Kim SS; Harford JB; Pirollo KF; Chang EH
Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of blood-brain barrier-stealth nanocomposites for in situ glioblastoma theranostics applications.
Su CH; Tsai CY; Tomanek B; Chen WY; Cheng FY
Nanoscale; 2016 Apr; 8(15):7866-70. PubMed ID: 27035391
[TBL] [Abstract][Full Text] [Related]
18. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
[TBL] [Abstract][Full Text] [Related]
19. Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance.
Strohbehn G; Coman D; Han L; Ragheb RR; Fahmy TM; Huttner AJ; Hyder F; Piepmeier JM; Saltzman WM; Zhou J
J Neurooncol; 2015 Feb; 121(3):441-9. PubMed ID: 25403507
[TBL] [Abstract][Full Text] [Related]
20. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
